查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827745

2025年全球关节痛注射市场报告

Joint Pain Injections Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，关节疼痛注射剂市场规模强劲成长，从2024年的56亿美元成长到2025年的61.2亿美元，复合年增长率为9.3%。预测期内的成长可归因于人口老化加剧、关节炎盛行率上升、全球健康倡议、医疗保健数位化以及人们对慢性疼痛管理的认识不断提高。

预计未来几年关节疼痛注射市场将快速成长，到2029年将达到97.7亿美元，复合年增长率为12.4%。预测期内的成长可归因于远端医疗服务的扩展、个人化疼痛管理、病患教育和赋能、永续的医疗保健实践以及营养支持。预测期内的主要趋势包括再生医学、个人化疼痛管理、创新註射材料、復健技术和人工智慧 (AI) 增强型注射。

关节疼痛注射透过减轻发炎和不适来发挥作用，通常直接注射到关节中以缓解疼痛。关节疼痛很常见，尤其是在老年人和已有疾病的人群中。关节炎等以疼痛和发炎为特征的疾病常常会引起关节疼痛。关节疼痛注射是一种非手术方法，可以快速缓解关节疼痛和发炎。

用于治疗关节疼痛的主要注射类型包括类固醇关节注射、透明质酸注射、富血小板血浆 (PRP) 注射、胎盘组织基质 (PTM) 注射以及其他各种注射。类固醇关节注射，也称为皮质类固醇注射，是一种用于治疗关节疼痛的抗发炎药物。它们对减轻发炎性关节炎（例如类风湿性关节炎）的发炎特别有效。关节疼痛注射可注射到各种关节，包括髋关节、膝关节、踝关节、肩关节、肘关节和脊椎的小关节。这些注射剂通常可在医院药局、零售药局和线上药局购买。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供关节痛注射剂市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的关节痛注射剂市场细分、市场趋势和商机，以及您在关节痛注射剂行业取得成功所需的数据。本关节痛注射剂市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为12.4%，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。美国可能会直接感受到这种影响，因为透明质酸製剂和皮质类固醇混悬液的供应链中断，这些药物主要来自瑞士和日本等主要地区，这可能导致骨关节炎治疗延误和整形外科疼痛管理成本增加。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响也可能波及更广泛的领域。

关节炎和肌肉骨骼疾病的日益普及预计将推动关节痛注射市场的成长。肌肉骨骼疾病是全球造成残疾的主要原因，其中腰痛被确定为160个国家中最常见的残疾原因。疼痛患者经常接受注射来缓解疼痛和控制发炎。例如，2023年6月，澳洲政府机构澳洲健康与福利研究所报告称，类风湿性关节炎占总疾病负担的2.0%，占肌肉骨骼疾病相关总疾病负担的16%。 2022年，报告的死亡人数为1,322人，相当于每10万人中有5.1人死亡，占所有死亡人数的0.7%。因此，关节炎和肌肉骨骼疾病的日益普及正在推动关节痛注射市场的发展。

预计慢性疼痛发病率的上升将推动关节痛注射市场的未来成长。慢性疼痛的特征是持续性或长期不适，持续时间较长，通常至少持续三到六个月，或超过预期的癒合期。关节痛注射通常用于治疗慢性疼痛，尤其是当它与骨关节炎、类风湿性关节炎等肌肉骨骼疾病和其他关节相关问题有关时。例如，2022 年 9 月，世界卫生组织 (WHO) 在 2022 年重点报告中报告中报告称，非传染性疾病 (NCD) 或慢性疾病将导致 4,100 万人死亡，占全球整体的 74%。因此，慢性疼痛发生率的上升正在推动关节痛注射市场的成长。

关节疼痛注射市场的一个显着趋势是越来越注重新产品开发。该领域的主要企业正在积极进行新产品创新，以满足消费者需求并巩固其市场地位。例如，总部位于英国的治疗性水凝胶製造商Contura International Ltd.于2021年9月推出了Arthrosamid。 Arthrosamid是一种用于治疗膝关节骨关节炎的创新水凝胶注射剂，它利用不可生物降解的水凝胶技术，为膝关节骨关节炎疼痛提供强效、持久、安全且微创的治疗方案。

关节痛注射市场的主要企业正致力于开发创新产品，例如优先考虑患者便利性的单次注射剂型。单次注射剂型是一种给药系统，旨在透过单次注射给药固定剂量的药物，无需多次注射，并能长期持续治疗效果。例如，2024年7月，韩国化学公司LG化学有限公司在中国推出了Synovian，这是一种治疗膝关节骨关节炎的新型药物，采用便捷的单次注射剂型。该产品旨在占领一个价值约2000亿韩元（约1.5亿美元）的巨大市场。该产品采用专有技术开发，专注于以最少的给药努力提供有效的缓解，展现了满足患者需求的创新。

2022年11月，印度製药公司Biocon Biologics Limited以33.3亿美元收购了Viatris Inc.的生物相似药业务。此次收购将使Biocon能够利用Viatris丰富的经验和在全球市场的稳固地位，从而改善全球患者获得重要治疗药物的管道。这项策略性措施预计将增强Biocon的生物相似药产品组合，包括用于治疗类风湿性关节炎等免疫介导疾病的Adalimumab皮下注射用BS。 Viatris Inc.是一家总部位于美国的医疗保健公司，提供关节疼痛治疗服务。

关节痛注射市场的主要公司包括工业株式会社、Flexion Therapeutics Inc.、Zimmer Biomet Holdings Inc.、Sanofi SA、Anika Therapeutics Inc.、Abbvie Inc.、Bioventus Inc.、礼来公司、Ferring Pharmaceuticals Inc.、辉瑞公司、Teva Pharmaceutical Limited、强生服务有限公司、默克公司、葛兰素史克公司、诺华公司、GlaxoSmithKline Plc公司、Astra Zeneca控股公司、百时美施贵宝公司、勃林格殷格翰国际有限公司、武田製药有限公司、工业、第一三共株式会社、卫材株式会社公司有限公司、拜耳公司、安斯泰来製药公司、第一三共株式会社、卫材株式会社公司有限公司、EisaiAstellas生公司、益普生普生公司、益普生普斯Ltd.、迈兰公司、太阳製药工业有限公司、Wockhardt Ltd. Zydus Lifesciences Limited 等。

2024 年，北美是关节痛注射市场最大的地区。关节痛注射市场分析报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

关节痛注射市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

关节痛注射市场包括硬膜外类固醇注射、小关节注射、关节内粘稠补充疗法注射、皮质类固醇注射和透明质酸注射的销售。该市场的价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球关节痛注射：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球关节疼痛注射市场：成长率分析
  • 全球关节痛注射市场表现：规模与成长，2019-2024
  • 全球关节痛注射市场预测：规模与成长，2024-2029年，2034年
  • 全球关节痛注射剂：总目标市场（TAM）

第六章 市场细分

  • 全球关节痛注射市场（按註射类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 类固醇关节注射
  • 玻尿酸注射
  • 富血小板血浆（PRP）注射
  • 胎盘组织基质（PTM）注射
  • 其他类型的注射
  • 全球关节疼痛注射市场（按关节类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 髋关节
  • 膝盖和脚踝
  • 肩膀和肘部
  • 脊椎椎间关节
  • 其他关节类型
  • 全球关节痛注射剂市场：按分销管道、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院药房
  • 零售药局
  • 网路药局
  • 全球关节痛注射市场：细分：类固醇关节注射（按註射类型），实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 皮质类固醇注射
  • 联合类固醇注射
  • 全球关节痛注射市场：透明质酸注射细分市场（按註射类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 单剂量透明质酸注射
  • 多次注射玻尿酸
  • 全球关节痛注射市场：富血小板血浆 (PRP) 注射细分（按註射类型）、实际及预测（2019-2024 年、2024-2029 年、2034 年）
  • 自我 PRP 注射
  • 同种异体PRP注射
  • 全球关节痛注射市场：细分：胎盘组织基质 (PTM) 注射（按註射类型），实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 羊水注射
  • 胎盘细胞注射
  • 全球关节痛注射市场：按註射类型细分，其他注射类型（按註射类型），实际和预测，2019-2024 年，2024-2029 年，2034 年
  • 骨髓抽吸浓缩液（BMAC）注射
  • 干细胞注射
  • 基因改造细胞注射

第七章 区域和国家分析

  • 全球关节痛注射市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球关节痛注射市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 关节痛注射市场：竞争格局
  • 关节痛注射市场：公司简介
    • Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Abbvie Inc.
  • Bioventus Inc.
  • Eli Lilly and Company
  • Ferring Pharmaceuticals Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited
  • Johnson & Johnson Services Ltd.
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Roche Holding AG
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Takeda Pharmaceutical Company Limited

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年关节痛注射市场：提供新机会的国家
  • 2029年关节痛注射市场：细分市场带来新机会
  • 2029年关节痛注射市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21691u

Joint pain injections serve to reduce inflammation and discomfort, typically administered directly into the joint to alleviate pain. Joint pain is a common occurrence, particularly among the elderly or individuals with pre-existing medical conditions or disorders. Conditions such as arthritis, characterized by pain and inflammation, often contribute to joint pain. Joint pain injections offer a non-surgical approach to quickly relieve joint pain and inflammation.

The primary types of injections for joint pain include steroid joint injections, hyaluronic acid injections, platelet-rich plasma (PRP) injections, placental tissue matrix (PTM) injections, and various others. Steroid joint injections, also known as corticosteroid injections, are anti-inflammatory medications used to treat joint pain. They are particularly effective in reducing inflammation in individuals with conditions like rheumatoid arthritis and other forms of inflammatory arthritis. Joint pain injections are applied to various types of joints, including the hip joint, knee and ankle joints, shoulder and elbow joints, facet joints of the spine, and others. These injections are commonly distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The joint pain injections market research report is one of a series of new reports from The Business Research Company that provides joint pain injections market statistics, including joint pain injections industry global market size, regional shares, competitors with a joint pain injections market share, detailed joint pain injections market segments, market trends and opportunities, and any further data you may need to thrive in the joint pain injections industry. This joint pain injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The joint pain injections market size has grown strongly in recent years. It will grow from $5.6 billion in 2024 to $6.12 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increased aging population, arthritis prevalence, global health initiatives, healthcare digitalization, increasing awareness of chronic pain management.

The joint pain injections market size is expected to see rapid growth in the next few years. It will grow to $9.77 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to expansion of telehealth services, personalized pain management, patient education and empowerment, sustainable healthcare practices, nutritional support. Major trends in the forecast period include regenerative medicine, personalized pain management, innovative injection materials, rehabilitation technologies, artificial intelligence ai-enhanced injections.

The forecast of 12.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for hyaluronic acid formulations and corticosteroid suspension solutions, sourced from key regions such as Switzerland and Japan, which could lead to delayed osteoarthritis treatments and increased costs for orthopedic pain management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of arthritis and musculoskeletal disorders is expected to drive the growth of the joint pain injections market. Musculoskeletal disorders are the leading cause of disability globally, with low back pain identified as the most common cause of impairment in 160 countries. Patients often seek injections for pain relief and to manage inflammatory conditions. For example, in June 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that rheumatoid arthritis accounted for 2.0% of the total disease burden and 16% of the overall burden of disease related to musculoskeletal conditions. In 2022, it resulted in 1,322 deaths, equating to 5.1 deaths per 100,000 people, which represented 0.7% of all deaths. Therefore, the rising prevalence of arthritis and musculoskeletal disorders is driving the joint pain injections market.

The rising incidence of chronic pain is anticipated to drive the growth of the joint pain injections market in the future. Chronic pain is characterized by persistent or long-lasting discomfort that continues for an extended duration, typically defined as lasting at least three to six months or beyond the expected healing time. Joint pain injections are commonly utilized to manage chronic pain, particularly when it is linked to musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, or other joint-related issues. For example, in September 2022, the World Health Organization (WHO) reported in its 2022 Highlights that there were 41 million deaths, accounting for 74% of all fatalities due to noncommunicable diseases (NCDs) or chronic diseases globally each year. Consequently, the increase in the incidence of chronic pain is propelling the growth of the joint pain injections market.

A prominent trend in the joint pain injections market is the focus on new product development. Major companies in this sector are actively engaged in innovating new products to meet consumer demand and enhance their market position. For instance, Contura International Ltd., a UK-based manufacturer of therapeutic hydrogels, introduced Arthrosamid in September 2021. Arthrosamid, an innovative hydrogel injection for knee osteoarthritis, utilizes non-biodegradable hydrogel technology, providing a potent, long-lasting, secure, and minimally intrusive treatment for knee osteoarthritis pain.

Leading companies in the joint pain injections market are concentrating on developing innovations such as single-injection formulations, which prioritize patient convenience. A single-injection formulation is a type of drug delivery system designed to deliver a specific dose of medication in a single injection, offering sustained therapeutic effects over an extended period without the need for multiple doses. For example, in July 2024, LG Chem Ltd., a chemicals company based in South Korea, introduced Synovian, a new treatment for knee osteoarthritis in China that features a convenient single-injection formulation, making it the first of its kind in the country. The product aims to capture a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed using proprietary technology, it demonstrates innovation in meeting patient needs, focusing on providing effective relief with minimal administration effort.

In November 2022, Biocon Biologics Limited, a pharmaceutical company based in India, acquired the biosimilars business from Viatris Inc. for $3.33 billion. This acquisition enables Biocon to utilize Viatris' extensive experience and established presence in the global market, improving access to critical therapies for patients around the world. This strategic move is anticipated to enhance its biosimilars portfolio, including Adalimumab BS for subcutaneous injection, which is indicated for immune-related diseases like rheumatoid arthritis. Viatris Inc. is a healthcare company based in the US that offers joint pain medications.

Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The joint pain injections market consists of sales of epidural steroid injections, facet joint injections, viscosupplementation injections, corticosteroid injections and hyaluronic acid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Joint Pain Injections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on joint pain injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for joint pain injections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The joint pain injections market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Injection: Steroid Joint Injection; Hyaluronic Acid Injections; Platelet-Rich Plasma (PRP) Injections; Placental Tissue Matrix (PTM) Injections; Other Type Of Injections
  • 2) By Joint Type: Hip Joint; Knee And Ankle; Shoulder And Elbow; Facet Joints Of The Spine; Other Joint Types
  • 3) By Distribution channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Subsegments:
  • 1) By Steroid Joint Injection: Corticosteroid Injections; Combination Steroid Injections
  • 2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections; Multi-Dose Hyaluronic Acid Injections
  • 3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections; Allogeneic PRP Injections
  • 4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections; Placental Derived Cell Injections
  • 5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections; Stem Cell Injections; Genetically Engineered Cell Injections
  • Companies Mentioned: Seikagaku Corporation; Flexion Therapeutics Inc.; Zimmer Biomet Holdings Inc.; Sanofi S.A.; Anika Therapeutics Inc.; Abbvie Inc.; Bioventus Inc.; Eli Lilly and Company; Ferring Pharmaceuticals Inc.; Pfizer Inc.; Teva Pharmaceutical Industries Limited; Johnson & Johnson Services Ltd.; Merck & Co. Inc.; GlaxoSmithKline plc; Novartis AG; AstraZeneca plc; Roche Holding AG; Bristol-Myers Squibb Company; Boehringer Ingelheim International GmbH; Takeda Pharmaceutical Company Limited; Bayer AG; Astellas Pharma Inc.; Daiichi Sankyo Company Limited; Eisai Co. Ltd.; Ipsen SA; Mallinckrodt Pharmaceuticals Ltd.; Mylan N.V.; Sun Pharmaceutical Industries Ltd.; Wockhardt Ltd.; Zydus Lifesciences Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Joint Pain Injections Market Characteristics

3. Joint Pain Injections Market Trends And Strategies

4. Joint Pain Injections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Joint Pain Injections Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Joint Pain Injections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Joint Pain Injections Market Growth Rate Analysis
  • 5.4. Global Joint Pain Injections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Joint Pain Injections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Joint Pain Injections Total Addressable Market (TAM)

6. Joint Pain Injections Market Segmentation

  • 6.1. Global Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Steroid Joint Injection
  • Hyaluronic Acid Injections
  • Platelet-Rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Other Type Of Injection
  • 6.2. Global Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hip Joint
  • Knee And Ankle
  • Shoulder And Elbow
  • Facet Joints Of The Spine
  • Other Joint Types
  • 6.3. Global Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.4. Global Joint Pain Injections Market, Sub-Segmentation Of Steroid Joint Injection, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Corticosteroid Injections
  • Combination Steroid Injections
  • 6.5. Global Joint Pain Injections Market, Sub-Segmentation Of Hyaluronic Acid Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Hyaluronic Acid Injections
  • Multi-Dose Hyaluronic Acid Injections
  • 6.6. Global Joint Pain Injections Market, Sub-Segmentation Of Platelet-Rich Plasma (PRP) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autologous PRP Injections
  • Allogeneic PRP Injections
  • 6.7. Global Joint Pain Injections Market, Sub-Segmentation Of Placental Tissue Matrix (PTM) Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amniotic Fluid Injections
  • Placental Derived Cell Injections
  • 6.8. Global Joint Pain Injections Market, Sub-Segmentation Of Other Types of Injections, By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Marrow Aspirate Concentrate (BMAC) Injections
  • Stem Cell Injections
  • Genetically Engineered Cell Injections

7. Joint Pain Injections Market Regional And Country Analysis

  • 7.1. Global Joint Pain Injections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Joint Pain Injections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Joint Pain Injections Market

  • 8.1. Asia-Pacific Joint Pain Injections Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Joint Pain Injections Market

  • 9.1. China Joint Pain Injections Market Overview
  • 9.2. China Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Joint Pain Injections Market

  • 10.1. India Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Joint Pain Injections Market

  • 11.1. Japan Joint Pain Injections Market Overview
  • 11.2. Japan Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Joint Pain Injections Market

  • 12.1. Australia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Joint Pain Injections Market

  • 13.1. Indonesia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Joint Pain Injections Market

  • 14.1. South Korea Joint Pain Injections Market Overview
  • 14.2. South Korea Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Joint Pain Injections Market

  • 15.1. Western Europe Joint Pain Injections Market Overview
  • 15.2. Western Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Joint Pain Injections Market

  • 16.1. UK Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Joint Pain Injections Market

  • 17.1. Germany Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Joint Pain Injections Market

  • 18.1. France Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Joint Pain Injections Market

  • 19.1. Italy Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Joint Pain Injections Market

  • 20.1. Spain Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Joint Pain Injections Market

  • 21.1. Eastern Europe Joint Pain Injections Market Overview
  • 21.2. Eastern Europe Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Joint Pain Injections Market

  • 22.1. Russia Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Joint Pain Injections Market

  • 23.1. North America Joint Pain Injections Market Overview
  • 23.2. North America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Joint Pain Injections Market

  • 24.1. USA Joint Pain Injections Market Overview
  • 24.2. USA Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Joint Pain Injections Market

  • 25.1. Canada Joint Pain Injections Market Overview
  • 25.2. Canada Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Joint Pain Injections Market

  • 26.1. South America Joint Pain Injections Market Overview
  • 26.2. South America Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Joint Pain Injections Market

  • 27.1. Brazil Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Joint Pain Injections Market

  • 28.1. Middle East Joint Pain Injections Market Overview
  • 28.2. Middle East Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Joint Pain Injections Market

  • 29.1. Africa Joint Pain Injections Market Overview
  • 29.2. Africa Joint Pain Injections Market, Segmentation By Type Of Injection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Joint Pain Injections Market, Segmentation By Joint Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Joint Pain Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Joint Pain Injections Market Competitive Landscape And Company Profiles

  • 30.1. Joint Pain Injections Market Competitive Landscape
  • 30.2. Joint Pain Injections Market Company Profiles
    • 30.2.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Flexion Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Joint Pain Injections Market Other Major And Innovative Companies

  • 31.1. Abbvie Inc.
  • 31.2. Bioventus Inc.
  • 31.3. Eli Lilly and Company
  • 31.4. Ferring Pharmaceuticals Inc.
  • 31.5. Pfizer Inc.
  • 31.6. Teva Pharmaceutical Industries Limited
  • 31.7. Johnson & Johnson Services Ltd.
  • 31.8. Merck & Co. Inc.
  • 31.9. GlaxoSmithKline plc
  • 31.10. Novartis AG
  • 31.11. AstraZeneca plc
  • 31.12. Roche Holding AG
  • 31.13. Bristol-Myers Squibb Company
  • 31.14. Boehringer Ingelheim International GmbH
  • 31.15. Takeda Pharmaceutical Company Limited

32. Global Joint Pain Injections Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Joint Pain Injections Market

34. Recent Developments In The Joint Pain Injections Market

35. Joint Pain Injections Market High Potential Countries, Segments and Strategies

  • 35.1 Joint Pain Injections Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Joint Pain Injections Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Joint Pain Injections Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer